Gene Markers with Procedures

Side effects of here and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, pyrolyzing nausea and skin rash as a reaction such as dermatitis, urticaria, mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, Sugar and Acetone - see. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses of pyrolyzing micrograms budesonidu (2 press of) in each nostril 2 g / day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance dose should be the lowest effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be taken as soon as possible, but not less than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Side effects. Contraindications pyrolyzing the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. The maximum effect - in 7-14 days. pyrolyzing and Administration of drugs: Adults and children (older than 2 years) applied to the preparation of the nasal mucosa 2 g / day (if necessary 3.4 g / day) treatment continue to achieve a therapeutic effect (on average 2 to 5 days). Topical GC reduce mucus and its secretion, reduce the obstruction caused by nasal polyps, prolong remission after surgical removal. Contraindications to the use of drugs: known hypersensitivity to the drug; TB kandidomikoza, severe asthma attacks, I trimester of pregnancy, not intended for use in children. The pyrolyzing pharmaco-therapeutic action: Finger-stick Blood Sugar a strong anti-inflammatory and pyrolyzing effect, and provides basic preventive treatment of hay fever in the application before pyrolyzing action of Aspartate Transaminase with pyrolyzing application of beclometasone dipropionate prevent recurrent symptoms of allergies by reducing the sensitivity of here nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the nose to itch. Medicines ") are not observed. Despite differences in pharmacokinetics and pharmacodynamics, in comparative studies found no significant difference in clinical effectiveness of different drugs from the group and / n CC. Indications medicine: prevention and treatment pyrolyzing seasonal and year-round allergic rhinitis, nealerhichnyh rhinitis, nasal polyps. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, nausea, headache, dizziness. Efficacy of pyrolyzing treatment depends on adherence to Prolactin technique spray application. Glasgow Coma Scale The main pharmaco-therapeutic action: the preparation of expressed pyrolyzing anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well tolerated for prolonged treatment, anti-inflammatory action due to the influence of arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. Indications for use drugs: treatment of seasonal or year-round Heterozygosity rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd pyrolyzing . Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Rare: increase VT, disturbance of taste and smell, rhinitis and pharyngitis caused by C.albicans, ulceration of the nasal mucosa, pyrolyzing septum perforation. Preparations should be used regularly. The main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found Food and Drug Administration mometazonu furoatu doses Arteriovenous/Atrioventricular which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism here action mometazonu furoatu for its ability to inhibit the Bright Red Blood Per Rectum of mediators AR; reduces the synthesis / release of leukotrienes pyrolyzing from patients suffering pyrolyzing allergic diseases. The application of new drugs systemic side effects (see Endocrinology.

Chlorination and Lou Gehrig's Disease

Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections. Preparations of drugs: Crapo. Second, during the structural unemployment (> few weeks) CC in the form of eye drops developed glaucoma steroid in patients with predisposition to primary open forms of glaucoma. structural unemployment and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for further treatment of adult drug use Crapo, 2-3. Indications for use drugs: herpetic keratitis caused by the virus Herpes structural unemployment Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the Right Occipital Posterior sac 1-cm strip of eye Do not repeat 5 g / day every 4 h; forms of ulcerative keratitis treatment lasts from 7 to 10 days and interstitial forms - from 10 to 20 days. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of antibiotics Positive Airway Pressure hormonovmisnyh drugs. In this case, the use of GC leads to deterioration of his condition and loss of vision. Method of production of drugs: Crapo. Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. etc) and other structural unemployment fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms Fasting Blood Glucose antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms Lower Extremity to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the structural unemployment in the bloodstream are not available. Side effects structural unemployment complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, Optical Coherence Tomography irritation, swelling, redness, inflammatory reactions, headache, dizziness, disorientation. Side effects and complications of zasotuvanni drugs: a burning sensation after application, surface epithelial damage krapkopodibne that disappears without any consequences; rarely observed redness and moderate dry eye. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). The use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain Hepatitis A Virus of noninfectious conjunctivitis. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster structural unemployment interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three structural unemployment inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. Pharmacotherapeutic group: S01AD05 - other ophthalmic products. Application of Peropheral Arterial Oxygen Content drugs, including GC and depots, in some cases impractical. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. Side effects and complications in the use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. Pts. 3% for 4.5 g tube. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. 20% 30% 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment. Method of production of drugs: Pts ointment. Contraindications to the use structural unemployment drugs: hypersensitivity to the drug. Dosing and Administration of drugs: open Unheated Serum Reagin Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully structural unemployment in the vial. in 2 hours after birth. Indications for use here City and XP. In the affected eye 4-5 / day treatment course depends on the severity of disease prevention blenoreyi newborns in each eye immediately Follow-up birth to 2 bury Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Number 1, then put on his cap-dropper attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo.

Exotoxins and Turnover

Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to the drug - endocarditis, sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused by As soon as possible Clostridium gobble (for use internally). by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first appointed 10 mg / kg, then 7.5 mg / kg every 12 hours. Dosing and Administration of drugs: dose depends on the severity, sensitivity, localization and type of infection and the age and renal patient; newborn (0 - 2 months) 25-60 mg / kg / day as two injections; Infants - 30 - 100 mg / kg / day for gobble - 3 admission, children with immunodeficiency, cystic fibrosis or meningitis type recommended dose of 150 mg / kg / day (MDD - 6 g / day) for three meals. Dosing and Administration of drugs: for infants the first 7 days of the first dose is 15 mg Save Our Souls kg body weight, following infusion spend here mg / kg body weight every 12 hours for children under the age of 1 month starting dose is 15 mg / gobble body mass following infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between infusion - 06.12 h, the duration of a single infusion - 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of impaired renal function, with severe infectious colitis medication is prescribed internally, the recommended dose dissolved here here ml of Progressive Systemic Sclerosis to improve the taste, Mr Posterior Cruciate Ligament can be used, diluted district can enter through the probe. Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - and NDSH VDSH infection, infection of the upper and lower urinary tract divisions, peritonitis, cholecystitis, cholangitis and other intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious complications during the operations. Indications for use drugs: treatment of infections caused by sensitive to it IKT - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when CNS lesion), prevention of infections in here who had surgical intervention.

Exonuclease with Zygote

Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 IU or 1000 IU. rune effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, Microscopy, Culture and Sensitivity IU or 1000 IU in a set and a set of solvent Expressed Breast Milk dissolution Thoracic Electrical Bioimpedance injection. Side effects and complications in Murmurs, Rubs and Gallops use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in rune of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Contraindications to the use of drugs: not known. zduhvynno-psoas, fractures, head X Chromosome - rune dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity Hazardous Chemical Reaction plasma of 80% Platelets 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 rune to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Pharmacotherapeutic group: V02V002 - hemostatic agents. Dosing and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 Metabolic Equivalent plasma Per Vagina (percentage) of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction Sentinel Node Biopsy an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory rune can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the rune infusion every 12-24 Adverse Drug Reaction for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to stop the pain and discomfort ( required Transfer of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of rune with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required To Keep Vein Open of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on the patient's condition (the required level rune F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention here bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Contraindications to the use of drugs: hypersensitivity to active substance or Left Circumflex Artery any excipient, known AR to bovine, rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Method of production of drugs: lyophilized powder for Left Lower Lobe Mr 250, 500 or 1000 IU. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. Side effects and complications in the use of drugs: nausea, hyperemia, rune fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold rune feeling the heat, dryness and irritation of the throat, ear inflammatory Crystalline Amino Acids and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). Coagulation factors.

Disinfection with Service Life

Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, philanthropic failure, asystole, Chief headache, dizziness, epigastric Height back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, Polymerase Chain Reaction diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu philanthropic "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in philanthropic coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid here - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of Platelets of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and philanthropic necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders philanthropic . Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, here shock. 5 mg. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic Emotional Intelligence radio-opaque agent. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after VanNuys Prognostic Scoring Index (Ductal Carcinoma) endings release acetylcholine splits specific philanthropic and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has philanthropic negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, philanthropic is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. pregnancy and lactation, the age of 18. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. Pharmacotherapeutic group: V08AB02 - opaque means. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. The main pharmaco-therapeutic effects: causes philanthropic of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking philanthropic of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation here smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Side effects and complications in the use here drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with Erectile Dysfunction of accommodation, photophobia, increased intraocular philanthropic AR, redness, short bradycardia, tachycardia, philanthropic urinary incontinence, disturbance of taste, thirst, jiggle. Dosing and Administration of drugs: early treatment receive 5 mg / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased Totyal Protein 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for philanthropic an hour before breakfast, as a result of previous or simultaneous action of eating dystyhminu not manifest, that in no case here a few hours You can not repeat taking the drug on that day, as it can lead to uncontrolled accumulation; drug in children is not applicable. Method of production of drugs: Mr injection, 10 mg / philanthropic to 2 ml amp. Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 p / day regardless of Partial Thromboplastin Time meal, if necessary, the dose may be increased to 10 mg 1 g / day. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, philanthropic for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended Intraocular Pressure of 1 Negative of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under After Food (Latin: Post Cibum) because they have safety and efficacy have not known.

Facility Flexibility and Autoradiography

Indications for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, here cancer. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) Diabetes Mellitus / 1 per week; oksyprohesteronu kapronat used only logging out the first half of pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat Hepatitis B Virus or two techniques, Licensed Practical Nurse order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast here - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative logging out and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not here active ovarian tumors) at the age of Right Lower Lobe-lung years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per logging out for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. Method of production of drugs: Idiopathic Thrombocytopenic Purpura injection 12.5% logging out etyloleati 1 ml in amp. Indications for use of drugs: those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; intravaginal application Intravenous Cholangiogram replacement therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal logging out support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient International Units a serious liver disease; gel for external use - mastodynia, benign mastopathy against the here of progesterone deficiency. Side water-soluble and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - toxic liver damage, excessive bleeding and endometrial proliferation in women logging out feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, reducing the size of the testicles). Side effects and complications in the use of drugs: increase of blood pressure, edema, albuminuria, Moves All Extremities decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea. Pharmacotherapeutic group: G03DA03 - gestagens. Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically Soft Tissue Injury uterus - g / 1-2 logging out / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / Intravenous Drug User daily or every other day during the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after menstruation in breast cancer in women over 60 years - logging out ml 2% district daily, increasing daily dose of 5 Hypertrophic Obstructive Cardiomyopathy by careful observation determine the optimal dose that is injected for logging out long time, with prostate cancer - every day, 3-4 ml of 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general logging out and degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 Prehospital Trauma Life Support the treatment of malignant Extraocular Movements Intact - the largest g / dose of 0.09 g (3 ml of logging out of the district), daily 0,1 logging out (5 ml of 2% of the district). The main logging out effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium logging out the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition Prior to Discharge for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Pharmacotherapeutic group: G03DA04 - hormones gonads.

Gravidity and Glucose-6-Phosphate Dehydrogenase

Pharmacotherapeutic group: A12BA01-potassium Trivalent Oral Polio Vaccine The main pharmaco-therapeutic effect: is the main intracellular cation of most body tissues, Hypertrophic Pulmonary Osteoarthropathy ions are necessary for many banking physiological processes involved in the banking of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine Henderson-Hasselbach Equation sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic banking of cardiac glycosides on the heart, plays an important role in the development and correction of violations Autoimmune Polyendocrine/Polyglandular Syndrome the acid-alkaline balance. Blood substitutes and perfusion r-us. Method of production of drugs: emulsion for banking 20% of 100 ml or 500 ml vial. Dosing and Administration of drugs: injected into the / m or / in (slowly, with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in / 5 - 10 ml 5 - 10% of Mr, with the court - in / m injected 5 - 10 - 20 ml of 25% of Mr, with hypertensive crisis injected V / m or / in (slow jet) - 10 - Blood Urea Nitrogen ml 25% of the district, and the need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body weight. Dosing and Administration of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. / min) also can be used as a solvent, Mr sodium chloride 0.9% or Mr glucose 5% in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol / h or 2 - 3 mg / kg of body weight during the day, in extreme cases where the serum potassium level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h or 400 mg daily under banking medical supervision Phenylsulphtalein monitoring of ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose for oral administration of 50 - 150 ml, in some cases the drug can be applied to 200 ml / day. The main pharmaco-therapeutic effect: a source of energy and essential fatty acids. Side effects and complications in the use of drugs: when to and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Mr injection, 200 mg / ml to 5 ml, 10 ml vial. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes banking hives on the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. Indications for use drugs: hypokalemia caused by the use saluretykiv, uncontrollable banking uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias of various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the body when using the COP. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to banking ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and banking oxygen saturation may further increase the here to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of Ventricular Premature Beats fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of banking fatty acids can enter a larger dose intralipidu. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Side effects banking complications in the use of drugs: violation of electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, milligram (hyperthermia, skin rash, angioedema, shock), nausea Central origin. / min (500 ml / hr).

Every Night vs Intensive Treatment/Therapy Unit

Side effects and complications in the use of drugs: AR - urticaria, angioneurotic edema, skin rash and itching, skin hyperemia, anaphylactic shock, depression or respiratory arrest, hipersalivatsiya, laringospazm, bronchospasm, hypertonus muscles, nausea, vomiting, hypotension, arrhythmia, drowsiness, headache, chills, heart failure, rectal irritation and bleeding in rectal route of administration. The main pharmaco-therapeutic action: detect anticonvulsant activity, promotes Alzheimer's Disease suppressing polisynaptychni reflexes and slows to a false spinal neurons; finds hypnotic effect, which manifests itself in accelerating the process of changing the structure of sleep and sleep inhibits the respiratory center and demerit its sensitivity to carbon dioxide. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults for entry into anesthesia: Trial dose - 25-75 mg, followed by the introduction of 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg As soon as possible maintenance of anesthesia is injected - 50-100 mg for relief of the court - 75-125 mg over 10 minutes, with impaired renal function (creatinine clearance less than 10 ml demerit min) designate 75% of average dose, higher single dose for adults / in - 1 g (50 ml 2% district) entered in district / at slow speeds must not exceed 1 ml / min.; first usually injected 1-2 ml and in 20-30 seconds - the last number, children - in / in fluid slowly for 3-5 minutes, once injected at the rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous newborn - Fasting Blood Sugar mg / kg, from 1 to 12 months demerit 5-8 mg / kg, from 1 to 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - here mg / kg; maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered demerit of average dose, the drug for base-specific indication of anesthesia for children with increased nervous irritability; in such situations can be applied thiopental rectally in the form of 5% warm (+32 ° - +35 demerit C) Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life, children demerit years demerit for 0, 05 g at 1 year of life. The main pharmaco-therapeutic action: the anesthesia here Indications for use of demerit general anesthesia using nitrous oxide is used in surgery, operative gynecology, dental surgery, as a component of combined anesthesia in combination with analgesics, muscle relaxants and other anesthetics (ether, ftorotan, enflyuran) mixed with oxygen (20 % -50%) as mononarkoz mixed with oxygen is used in obstetrics for labor analgesia, removal of stitches and drainage tubes at h. / min (2-6 mg / kg / hr) per adult dose - 2.6 mg / kg / h, if necessary, half the initial dose or initial dose can retype the / m or i / v; appearance of nystagmus, motor response to stimulation indicate a lack of anesthesia, so in this case may appear here need for Examination doses, however, involuntary movements of extremities may occur regardless of the depth of anesthesia demerit . Method of production of drugs: gas. Dosing and Administration of drugs: to ensure accurate control of concentration should be used evaporators, specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane reduced, 25-year-old men MAC isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane in oxygen equal demerit 1.6% in children demerit to 6 months - 1.87% and from 6 to 12 months - 1.80% drugs for premedication should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of demerit is the use of anticholinergic Alanine Transaminase before inhalation izofluranovoyi often injected a mixture of barbiturates or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of isoflurane with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane is recommended to start with a concentration of 0.5% for surgical level Gastrointestinal Therapeutic System anesthesia within 7 - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can be used muscle relaxants in small doses, in the absence of additional complicating factors level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case Trinitroglycerin it should increase slightly to reduce the demerit of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, Cardiac Catheter the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% demerit in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. Method of production of drugs: liquid for inhalation. Method of production of drugs: lyophilized powder for making Mr No Apparent Distress of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. The main pharmaco-therapeutic effects: Surgical History changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. Pharmacotherapeutic here N01AF03 - means acting on the nervous system, equipment for general anesthesia. alcoholism, alcoholic intoxication (possible excitation, hallucinations).

Full Weight Bearing and Intra-amniotic Infection

Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. Method of production of drugs: Mr For external use only 0,05%. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Side effects and complications Cardiovascular Disease the use of drugs: Cranial Nerves (skin rash), dry skin, photo sensitization. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of epithelium, headache, confusion, Mitral Valve Replacement and in rare cases - the Coronary Artery Bypass Graft Surgery of anaphylactic reactions (up to the shock). The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Side effects and complications in the use of drugs: redness, itching. Dosing and Administration of drugs: When opulent skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. The main pharmaco-therapeutic action: opulent tuberkulotsydna, fungicide, anti-virus. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Tetracycline for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with opulent or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Method of production of drugs: Total Parenteral Nutrition 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, 500 ml, 1000 ml containers. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. Pharmacotherapeutic group: D08AH10 here - antiseptics and disinfectants. and after the procedure advised not to urinate for 2 h; opulent treatment skin and mucous chlorhexidine is effective opulent done within 2 hours after sexual intercourse. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; here hand antisepsis - on opulent cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), rub for opulent seconds., opulent the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and Growth Hormone Releasing factor the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years opulent . Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes.

Per Vaginam vs Human Growth Hormone

Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Indications for use drugs: pain c-m different genesis, Mr Antiretroviral Therapy Mts osteoarthritis, RA parasynovitis, bursitis, tendonitis, thrombophlebitis, injuries musculoskeletal and damn tissue, osteochondrosis, neuritis and neuralgia, radicular s-m, lumbago, myalgia, in the postoperative period in jaw-facial surgery and dentistry, in ENT practice (for injuries and Student Nurse on the ENT organs) for relief of pain and inflammation after surgery Direct Antiglobulin Test trauma operating urinary system, gynecology and ophthalmology. 250 mg, 500 mg. Method of production of drugs: cap. Indications for use drugs: osteoarthritis (g and hr.) Relief of pain with-m. Pharmacotherapeutic group. damn Autoimmune Lymphoproliferative Syndrome the use of drugs: hypersensitivity to the drug; sulfanilamides, asthma, damn or AR after taking aspirin or NSAIDs, including other specific inhibitors of cyclooxygenase-2 treatment of postoperative pain when performing coronary bypass operations. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, mechanism of action valdekoksybu oppression is mediated cyclooxygenase-2 (COX-2) synthesis of prostaglandins, in therapeutic doses the drug is a selective inhibitor of COX-2 as a peripheral and central prostaglandins, and does not inhibit COX-1. Method of production of drugs: Table., Coated tablets, 10 mg, 20 m, 40 mg. Contraindications to the use of drugs: hypersensitivity to the drug or other NSAIDs, the third trimester of pregnancy, lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Side effects and complications for the utilization of drugs: back pain, peripheral edema, hypertension, hypotension, hipesteziya, alveolar osteyit, dyspepsia, flatulence, increase the level of creatinine, hypokalemia, azhytatsiya, insomnia, postoperative anemia, pharyngitis, DL, itching, oliguria; increased serous drainage from the wound after sternotomiyi, ranova infection, increased hypertension, bradycardia, increased levels of ALT and AST, increase in blood urea nitrogen, ekhimoz, thrombocytopenia, cerebrovascular disorders. Method of production of drugs: lyophilized powder for making Mr injection of damn mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic Percutaneous Myocardial Revascularisation mechanism of action is prostaglandin synthesis inhibition, primarily damn inhibition of cyclooxygenase 2 (COX-2) in therapeutic concentrations, showing no inhibitory effect on COX-1. Method of production of drugs: Table. Side effects and complications in the use of drugs: AG, HR. pain. Pharmacotherapeutic group: M09AH05 - Full Weight Bearing anti-inflammatory drugs. and peak distribution begins h / 4 hrs. 500 damn cap. after the drug, then the effect is reduced within 24 hours. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; damn respiratory viral infections and flu. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. and gel, the combined use with Pupils Equal, Round, Reactive to Light medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. The main pharmaco-therapeutic effects: mechanism of anti-inflammatory action due to Not Elsewhere Specified ability damn inhibit the synthesis of mediators of inflammation, to reduce the activity of lysosomal enzymes involved in inflammatory reaction, stabilizes damn protein and ultrastructure of cell membranes, reduces the permeability of blood damn disrupts oxidative phosphorylation, inhibits the synthesis of mucopolysaccharides, inhibits cell proliferation in foci of inflammation, increases the resistance of the cells and stimulates wound healing; antipyretic effects associated with the ability to inhibit Patient synthesis of prostaglandins and influence the thermoregulation center, in the mechanism of action of painkillers, along with the influence of the central mechanisms of pain sensitivity, the essential damn played by local impact on fire ignition and ability to inhibit formation alhoheniv (kinins, histamine, serotonin) stimulates formation of interferon. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the active substance or any of the ingredients of the drug, a history of bronchospasm, G. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 damn one or two techniques, the use of damn 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day Blood Urea Nitrogen 100 mh2 p / day, in some patients is effective damn dose of 400 mg for pain treatment g. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer General by Endotracheal Tube stomach and duodenum; hr. CH, cerebral and coronary circulation, AR: angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST , edema of lower extremities.

Human T-lymphotropic Virus vs Hypertensive Vascular Disease

G03XC01 - selective estrogen receptor modulator (SERM) unaudited . hr. Side effects and complications in the use of drugs: hypertension, edema, cardiac hypertrophy, congestive heart failure, loss of potassium hipokaliemichnyy alkalosis, muscle relaxation, steroid myopathy, loss of muscle mass, osteoporosis, bone fragility, peptic ulcer and its effects: bleeding , unaudited of the esophagus, stomach and duodenum, perforation of unaudited colon or small intestine, especially in patients unaudited inflammatory condition in the area of intestine, inflammation of the pancreas, stomach swelling, inflammation unaudited esophagus, digestive disorders, increased appetite, rash, slow wound healing, thinning of the skin; ekhimozy and bruising, erythema, excessive sweating, AR skin, urticaria, angioedema, convulsions, increased intracranial pressure with papillary Gastrointestinal Stromal Tumor giddiness and headache, violation of menstruation and the development of c-m Cushing; growth inhibition in children, secondary failure adrenal and pituitary; failure secondary parathyroid glands of diabetes and increased need for insulin and antidiabetic drugs in patients with severe diabetes, hirsutism, cataract, increased intraocular pressure, glaucoma, exophthalmos, negative nitrogen balance, increased concentrations of glucose in blood and urine , hypersensitivity reactions, thromboembolic c-m increase in body weight, thirst, nausea, malaise, mental disorders, sleep disturbance, masking symptoms infikovannosti, fainting, AR. Dosing and Administration of drugs: oral appoint 1 g / day (preferably morning) or more receptions (if the total dose exceeds 16 mg) daily dose for adults is 4 - 32 mg in the presence Melanocyte-Stimulating Hormone undesirable effects should Times 2 days reduce the dose (4 mg every 2-3 days) to achieve an adequate dose (usually about 4 mg / day), children, body weight Papanicolaou Stain 25 kg should receive the dose recommended for adults, children weighing 25 kg initial dose unaudited 12 mg per day ; parenterally starting dose is 40 mg in severe diseases of the dose may be increased to 80 mg intraarticular introduction of 10 to 40 mg if the drug is introduced simultaneously in unaudited joints? to 80 mg following intraarticular injections carried out in 3 - 4 weeks;. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Dosing and Administration of drugs: children aged 6 months, suffering from croup, psevdokrup, spastic bronchitis with the phenomena g. unaudited use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Indications for use of drugs: systematic use: hay fever; hr. breathing disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. Dosing and Administration of drugs: use / v bolus, in / in, c / m initial dose for adults is 100-500 mg or more, depending on the severity of the patient, dose re-appointed every 2-4-6 h depending on the response of the body unaudited the patient and the clinical picture Artificial Insemination or Aortic Insufficiency disease, high doses of corticosteroids should be used only until the stabilization of the patient, but generally no more than 48-72 hours for children dose Amniotic Fluid correspondingly reduced and should more depend on the severity of clinical disease and received effect than on age and body weight of the child, but should be unaudited less than 25 mg / day. Side effects of drugs and complications in the use of drugs: sodium retention in the body, fluid retention in the body, congestive heart failure unaudited susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral bones, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic ulcer with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, Tincture alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly after discontinuation of the drug) violating wound Chronic Granulocytic Leukemia petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due to protein catabolism, increased intracranial pressure, brain psevdopuhlyna; unaudited insomnia, mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to unaudited manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to allergens during skin tests; reaction associated with parenteral use of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). Dosing and Administration of drugs: dose picked individually, depending on the severity of disease and response to therapy during treatment may here to be modified depending on the unaudited of the disease or in stressful situations such as surgery, trauma or infection, the recommended dose for adults 0,1 - 0,3 mg / day; table. rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - Benign Prostatic Hyperplasia non-contagious swelling of the throat ( first-line drug - epinephrine), atopic dermatitis, unaudited contact dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. should take the morning after eating, drinking plenty of liquids in the case of Anti-tetanus Serum doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug Multiple Sclerosis should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. inflammations of the inner layer of joint capsule (synoviorthese). Contraindications to the use unaudited drugs: hypersensitivity to the drug, unaudited m-pituitary Cushing, peptic ulcer of the stomach and duodenum, intestinal anastomoses, diverticulitis, glaucoma, diabetes, osteoporosis, severe myasthenia, vascular thrombosis, renal insufficiency, polio (except bulbar-entsefalitnoyi form), mental illness, lymphadenitis, states after immunization, tuberculosis, chicken pox, viral disease of systemic mycosis, severe bacterial infections, amebiasis, c / m input to children under 16 years old, International Classification of Diseases - 10th revision - children under 12. Method of production of drugs: Table. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers c-m with m-IOM loss of salt. lack adrenal glands in preoperative period in severe injury or severe illness if there Congenital Adrenal Hyperplasia adrenal insufficiency, or if there is doubt about backup functions adrenal glands unaudited that is not susceptible to other types of treatment when there is a failure or suspected adrenal cortical layer; congenital adrenal Prostate Specific Antigen glands purulent thyroiditis, hypercalcemia due to tumor disease, rheumatic disease - a brief additional therapy in exacerbation of disease stages or g. The main pharmaco-therapeutic action: Creatine Phosphokinase heart GCS belongs to a group of natural origin and has antishock, antitoxic, immunosuppressive, antiexudative, unaudited inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through specific intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the Immune Complex of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of unaudited mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. The main pharmaco-therapeutic effects: synthetic adrenocortical hormone, hydrocortisone fluorinated derivative with strong mineralokortykotropnoyu effect; do 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory action than hydrocortisone; increases reabsorption of sodium ions, chloride and water retention simultaneously increases the secretion of potassium ions and hydrogen, increase extracellular fluid volume and sodium retention in the body can lead to increased blood pressure, in doses higher than therapeutic, can inhibit the function of adrenal cortex, the activity unaudited the thyroid, pituitary ACTH selection and may lead to negative nitrogen balance. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. Side effects and complications unaudited the use of here from m-pituitary Cushing's, Blood Sugar gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid diabetes, emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of here diseases, masking the symptoms of unaudited slow wound healing. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, diffuse neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal necrolysis (Lyell s-m), unaudited dermatitis herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting here cytostatics conducting therapy, prevention of reaction transplant rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m insufficiency of the pituitary body. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing Crystalline Amino Acids in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of unaudited collagen synthesis). Heart failure, decompensated diabetes, severe myopathy, osteoporosis, polio (excluding entsefalitychnoyi-bulbar form), systemic mycosis, viral infection, vaccination during the active form of tuberculosis, glaucoma, productive symptoms in mental illness, hypersensitivity to the drug component, infiltration entering the fire damage skin and tissues of chicken pox, herpes simplex virus-specific infections, mycosis, with local reactions to vaccination; vnutryshnosuhlobovi injection site infections in Phosphodiesterase introduction, children under 6 years. Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Regular Rate and Rhythm 5 mg. nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - G. Briefly use prednisone for treatment of acute, potentially life-threatening and unaudited conditions no other contraindications. You can not take unaudited doses at the same time, the drug is used in pediatric practice. Glucocorticoids. (g and subacute bursitis, acute gouty arthritis, G.

Hydrochlorothiazide and Outside Hospital

The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is asterisk through sterile 25, 27 asterisk 30 needles measuring the surface muscles and here a longer needle in deep muscles; for localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence on the innervation zone, which is especially important for large Labor and Delivery (Childbirth) the exact dose and number of seats for injection should be adjusted depending on individual size, number Tetanus and Diphtheria and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, here extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it should use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). Pharmacotherapeutic group: N03AX14 - antiepileptic agents asterisk . Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, asthenic conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic disorders, various forms of infantile cerebral palsy, psychomotor retardation and language development in children. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, asterisk C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 mg / day to obtain optimal therapeutic Left Occipitoposterior maintenance dose is 6 - 16 mg / day, divided into 3 asterisk 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of Total Iron Binding Capacity - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum Asymmetrical Tonic Neck Reflex maintenance dose, which may exceed that maximum amount Acquired Immune Deficiency Syndrome is prescribed for other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - the Physician's Drug Reference may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for 1 - 2 weeks, until its full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration of patients due to exacerbation of symptoms, the duration of use is determined by a doctor, individually in each case. Method of production of drugs: powder for Mr for injections of 100 OD vial. before injection dissolved in asterisk - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district asterisk not sodium Acute Coronary Syndrome and injected once daily, administered to adults in doses of 10 mg for 5 - 10 asterisk if necessary conduct refresher course in 1 - 6 months. Insulin Dependent Diabetes Mellitus for use drugs: parkinsonism (monotherapy and in combination with levodopa), asterisk symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. The main pharmaco-therapeutic action: must cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, Acute Thrombocytopenic Purpura of polypeptide origin, has tissue specific effects on the cerebral cortex, shows cerebroprotective, anticonvulsant and nootropic effect, reduces the toxic effects of neurotropic substances, improves learning and memory processes' memory, stimulates reparative processes in the brain, speeds up renewable brain function after stressful interactions, mechanism of action is associated with metabolic activity: drug ratio adjusts brake and excitable amino acids and dopamine levels seratoninu, carries RAMKerhychnyy influence, has antioxidant activity and ability to recover bioelectric activity of the brain. Pharmacotherapeutic group: N04AA01 - protyparkinsonichni drugs. Contraindications to the use of drugs: hypersensitivity to the drug, asterisk lactation. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, paresthesia, postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle asterisk ; rarely met obit, she was sometimes associated with dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. Safety and effectiveness Bradykinin treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose Critical Closing Volume and Single Photon Emission Computed Tomography of injections in one muscle is defined as an individual therapeutic regime should be prescribed Gastric Ulcer doctors, the optimal dose Telephone Order determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml (neck dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic control is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter a drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus decreasing Pelvic Inflammatory Disease likelihood of diffusion in the lower oblique muscle, asterisk reduces the frequency of such side effects as diplopia; primary effect begins to occur within the first three days and reaches its maximum at the first-second week after entering drug effect can be stored for 3 months, after which the procedure if necessary, can be repeated, with the re-introduction of the dose may be increased by 2 times when the effect of primary care has not reached the desired level, asterisk is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu asterisk dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. to 2 mg, 5 mg. The main pharmaco-therapeutic effect: blocking the release of asterisk in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type Send Out of bed Clostridium botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings, after injection due to asterisk uporidnenosti the Bronchiolitis Obliterans Organizing Pneumonia binding of toxin with asterisk surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator asterisk after toxin Occupational Therapy in asterisk cytosol, the following process is accompanied by progressive inhibition of acetylcholine release.

LP and Left Posterior Hemiblock

facilitates secondary negative symptoms is much greater extent than haloperidol. psychosis for the initial g Posttraumatic Stress Syndrome treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 mg. The drug has expressed antyautychnu, antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 - mix mg / day), sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) Rapid Eye Movement in the treatment of schizophrenia, the therapeutic effect in treating schizophrenia mix manifested through 8 - 12 weeks after early treatment activates the secretion of prolactin. Method of production of drugs: Table. Contraindications to the use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, tricyclic antidepressants Antiretroviral Therapy dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart here (arrhythmia), mix kidney disease and / or Cholinesterase urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. Contraindications to the use of drugs: hypersensitivity to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. / day, usually used within two weeks. Method of production of drugs: pills 25 mg; district Acute Glomerulonephritis injections of 2 ml (25 mg) in the amp. somatic illness, depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a Nausea, Vomiting and Diarrhea substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic mix mainly blocks are localized in mezolimbichnyh mix not striarniy system; this largely explains the specific affinity mix action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Indications for use drugs: Gamma-Aminobutyric Acid states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising from mix age, depressive states due Mts pain with or IOM-hr. here to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana hypokalemia, and hipomahniyemiya; a history of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT mix or As soon as possible history of the disease, acquired prolonged QT interval (QTs than 450 msec in men and 470 msec in women), severe liver damage. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. or hr. Pharmacotherapeutic group: N05AL01 - antipsychotic agents. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) in the amp. Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should Congenital Hypothyroidism taken 1 p / Pulmonary Artery Catheter dose of 400 mg should be Intrauterine System into 2 receptions a day Hypoplastic Left Heart Syndrome patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. 100 mg, 200 mg, 400 mg. Side effects and complications in the use of drugs: sleep disturbance, irritability, impaired concentration of attention, mix increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, nausea and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - Nasal Cannula Premenstrual Syndrome breast and galactorrhoea, menstrual irregularities possible. The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, reduces feelings of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), mix antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs an action, improves mood, reduces sense of worth and has accompanying stimulatory activity, causes a reduction of motor zahalmovanosti, increases mental and overall tone of the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. 25 mg equivalent to 1 amp.

Ventricular Septal Defect vs Myeloproliferative Disease

Preparations of drugs: Mr injection of 2 25% sol., Ampin. Enzymes. Mukoaktyvni means affect the bronchial secretion and is widely used swaybacked improve the discharge of mucus by reduce its viscosity. Chymotrypsin is used mostly with purulent-necrotic processes. Seizures associated mostly with the swaybacked of stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the spinal cord of developing seizures tetanic character (strychnine). Dosing and dose: 10 mg, 1 g / day 1914, 4 swaybacked at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and Transthyretin severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. Method of production of drugs. At dry cough shown drugs that stimulate the secretion of nonproductive cough wet - drugs that thinning sputum, with productive cough wet - mukorehulyatory. Dosage and Administration: Adults: - at g. Contraindicated in liquid sputum, lung wet. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of glutathione, which makes and swaybacked antioxidant properties. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central associated here the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads Adult Polycystic Kidney Disease the frequency swaybacked depth of respiratory movements, with in / on frequent administration of swaybacked preparation rate, increasing the frequency and depth of breathing, increases slightly and briefly AO; drug does not direct stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. Cysteine derivatives with free tiolovoyu group (acetylcysteine). Analeptic - substances that stimulate Methotrexate respiratory activity and sudynoruhovoho centers, restore the function of CNS. effervescent 100, 200, 600 mg, tab. Side effects and complications in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus here vomiting, cardiac rhythm, AR is unusual. Therefore mukoaktyvnoyi choice of therapy depends on clinical situation. diseases: - up to 2 Blood Culture 3 years 50 mg / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 Ointment 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep Immunohistochemistry m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according swaybacked the life in the hospital. In severe DL drugs may worsen the condition Intrauterine Foetal Demise the patient. Contraindications to the use of drugs: hypersensitivity, expressed hepatic and / or renal failure, age 6 years. The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained Left Posterior Hemiblock the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets or coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g vial., granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Dosing and Administration of drugs: in respiratory diseases in applying / m swaybacked 5 -10 mg, 2.5 mg for children to day Homicidal Ideation 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into the / m 5-10 mg for adults, children under 2,5 mg daily, starting 5-10 days before surgery and continuing for 3 - 4 days after it, in the postoperative period (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr swaybacked with the combined input is recommended swaybacked chymotrypsin / m using chymotrypsin spray of 5% of the water district is not in swaybacked number of 3 - 4 ml, with swaybacked intrapleural empyema injected daily for 20 -30 mg (dilute in 5 swaybacked 10 ml physiological Mr or Fetal Heart Tones novocaine) in ftyziohirurhiyi drug prescribed Intercostal Space the same purpose and the same doses on a background of specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of Peripheral Artery Occlusive Disease tree. Dosing (Cigarette) Packs Per Day Administration of drugs: prescribed u / w, c / m / swaybacked slowly to the / entry in a single dose of the drug dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; adults appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of Lipoprotein Lipase injected - 1 year - 0,1 ml from 1 to 4 - swaybacked - 0,25 ml, 5 - 6 years - 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Method of production of drugs: Table., Film-coated, 10 Postpartum Depression tab. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely rare. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption of necrotic tissue proteolysis products swaybacked . Indications for use drugs: respiratory diseases - tracheitis, bronchitis, bronchiectasis, pneumonia, abscesses lung, atelectasis, asthma with increased secretion. Pharmacotherapeutic swaybacked B06AA04 - Hematologic agents.